3″,5″-dimethoxybenzoyl-3′-amino-3′-deoxy adenosine-5′-triphosphates and pharmaceutical uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11440935
APP PUB NO 20210054015A1
SERIAL NO

16981242

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are compounds compound according to Formula (I), or a pharmaceutically acceptable salt, solvate, coordination complex or prodrug thereof: wherein, R1 and R2 are independently selected from (C1-C6) alkyl. The compounds have P2X3 receptor or P2X2/3 receptor antagonist activity and are useful for the treatment of diseases and disorders characterized by activation of those receptors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DANMIR THERAPEUTICS LLC24 DARTMOUTH LANE HAVERFORD PA 19041

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Li, Jie Winchester, US 741 3601
Mahadevan, Anu Nestford, US 11 89
Morency, Cynthia Andover, US 5 15
Pelleg, Amir Haverford, US 18 528

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 13, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 13, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 13, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00